Inflammation has to fight pathogens fast—but it can't get out of control. Researchers at the German Cancer Research Center ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

Researchers at the University of Southampton engineered four-pronged antibodies that cluster the CD27 immune receptor, ...

A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...

The anti-tumor immune response involves a series of complex steps mediated by various immune cells and signaling molecules.

Conventional vaccine adjuvants primarily rely on molecular binding and biochemical stimulation to activate immune responses, ...

Cells that are about to die send a signal to an executioner protein, but sometimes, those cells can fight back and regenerate ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...